Tumor-associated neutrophils induce apoptosis of non-activated CD8 T-cells in a TNFα and NO-dependent mechanism, promoting a tumor-supportive environment

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Oncoimmunology

• Publication date

  2017-09-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/2162402X.2017.1356965PMID 29147615PMCID PMC5674962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway

  2017cited by this paper
• The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.

  2016cited by this paper
• Type I IFNs induce anti‐tumor polarization of tumor associated neutrophils in mice and human

  2016influential reference
• Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy

  2016cited by this paper
• Survival of residual neutrophils and accelerated myelopoiesis limit the efficacy of antibody‐mediated depletion of Ly‐6G+ cells in tumor‐bearing mice

  2016cited by this paper
• Neutrophils in cancer: neutral no more

  2016cited by this paper
• T cell exclusion, immune privilege, and the tumor microenvironment

  2015cited by this paper
• Distinct Functions of Neutrophil in Cancer and Its Regulation

  2015cited by this paper
• IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis

  2015cited by this paper
• The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment

  2015cited by this paper
• Delayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN‐β

  2014cited by this paper
• Neutrophils recruit regulatory T‐cells into tumors via secretion of CCL17—A new mechanism of impaired antitumor immunity

  2014cited by this paper
• Tumor-induced perturbations of cytokines and immune cell networks.

  2014cited by this paper
• Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.

  2014influential reference
• Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer

  2013cited by this paper
• Modulation of CD8(+) T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells.

  2013cited by this paper
• Neutrophils Confer T Cell Resistance to Myeloid-Derived Suppressor Cell–Mediated Suppression To Promote Chronic Inflammation

  2013cited by this paper
• Reciprocal Relationship between Myeloid-Derived Suppressor Cells and T Cells

  2013cited by this paper
• Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression

  2013cited by this paper
• Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer

  2012cited by this paper
• Rat Mesenchymal Stromal Cells Inhibit T Cell Proliferation but Not Cytokine Production Through Inducible Nitric Oxide Synthase

  2012cited by this paper
• Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology

  2012cited by this paper
• Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives

  2012cited by this paper
• Coordinated regulation of myeloid cells by tumours

  2012cited by this paper
• Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells

  2011cited by this paper
• Modulation of human neutrophil survival and antigen expression by activated CD4+ and CD8+ T cells

  2010cited by this paper
• Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

  2010cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.

  2010cited by this paper
• Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

  2009influential reference
• The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapy.

  2009cited by this paper
• IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer

  2009cited by this paper
• Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1

  2009cited by this paper
• Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?

  2009cited by this paper
• T Cell Infiltrate Predicts Long-Term Survival Following Resection of Colorectal Cancer Liver Metastases

  2009cited by this paper
• Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

  2008cited by this paper
• Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.

  2008cited by this paper
• A Novel Small-Molecule Inhibitor of Transforming Growth Factor β Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth In vivo and Prevents Tumor Recurrence after Surgical Resection

  2007cited by this paper
• A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection.

  2007cited by this paper
• Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion.

  2005cited by this paper
• Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease1

  2005cited by this paper
• Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses

  2004cited by this paper
• Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

  2003cited by this paper
• Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells1

  2003cited by this paper
• Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells

  2003cited by this paper
• L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

  2003cited by this paper
• Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species

  2003cited by this paper
• Indoleamine 2,3‐dioxygenase contributes to tumor cell evasion of T cell‐mediated rejection

  2002cited by this paper
• Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism1

  2002cited by this paper
• Tumor-Infiltrating Macrophages Induce Apoptosis in Activated CD8+ T Cells by a Mechanism Requiring Cell Contact and Mediated by Both the Cell-Associated Form of TNF and Nitric Oxide1

  2001cited by this paper
• Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

  2001cited by this paper
• Synergistic action of pro‐inflammatory agents: cellular and molecular aspects

  2000cited by this paper
• Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN‐γ stimulation through a mechanism dependent on endogenous TNF‐α and IL‐1α

  2000cited by this paper
• Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-gamma stimulation through a mechanism dependent on endogenous TNF-alpha and IL-1alpha.

  2000cited by this paper
• Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege

  1999cited by this paper
• Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway.

  1998cited by this paper
• Fas ligand mediates activation-induced cell death in human T lymphocytes

  1995cited by this paper
• Induction of apoptosis in mature T cells by tumour necrosis factor

  1995cited by this paper
• Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation

  1995cited by this paper

• Longitudinal spatial profiling of neutrophils during adoptive T cell therapy in murine melanoma reveals distinct lymph node infiltration patterns across anatomical sites

  2026cites this paper
• Heterogeneous neutrophils: Key players in regulating tumor immunity.

  2026cites this paper
• Targeting neutrophil‐driven immunosuppression: A strategy to overcome immune checkpoint inhibitor resistance

  2026cites this paper
• Regulating the regulators via targeting CD38 in the tumor microenvironment.

  2026cites this paper
• Characterizing the Head and Neck Cancer Microenvironment: Implications for Immunotherapy and Prognosis.

  2026cites this paper
• Neutrophils in the hepatocellular carcinoma microenvironment: orchestrators of progression and immunity.

  2026cites this paper
• The human and murine immune systems: regulated by dichotomous molecules.

  2026cites this paper
• Human lung cancer neutrophils generate NETs with preserved anti-tumor cytotoxicity but impaired anti-migratory activity

  2025cites this paper
• Identification of copper metabolism-related subtypes, the development of a prognosis model, and characterization of the immune landscape in colorectal cancer

  2025cites this paper
• Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies

  2025cites this paper
• Optimized bacterial delivery approaches for precision immunotherapy in breast cancer models.

  2025cites this paper
• The Role of Tumor Microenvironment and Immune Cell Crosstalk in Triple-Negative Breast Cancer (TNBC): Emerging Therapeutic Opportunities.

  2025cites this paper
• Targeting myeloid cell immunometabolism to improve current non-small cell lung cancer therapies.

  2025cites this paper
• Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity

  2025cites this paper
• Decoding the Metabolic-Immune Axis: Neutrophil Glycolysis-Driven Tumor Niche Remodeling and Its Therapeutic Exploitation.

  2025cites this paper
• Immune checkpoint inhibitors and immunosuppressive tumor microenvironment: current challenges and strategies to overcome resistance

  2025cites this paper
• Clinical Implications of Mismatch Repair Deficiency in Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor

  2025cites this paper
• Genetic insights into neuroblastoma: the role of immune cell features.

  2025cites this paper
• Neutrophils matter: new clinical insights on their role in the progression of metastatic breast cancer

  2025cites this paper
• Tumor cells that resist neutrophil anticancer cytotoxicity acquire a prometastatic and innate immune escape phenotype

  2025cites this paper
• Global trends in tumor-associated neutrophil research: a bibliometric and visual analysis

  2025cites this paper
• Tumor-associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review)

  2025cites this paper
• Targeting tumor-associated neutrophils: A promising strategy in lung cancer immunotherapy

  2025cites this paper
• Bidirectional role of neutrophils in tumor development

  2025cites this paper
• Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy

  2025cites this paper
• Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

  2025cites this paper
• Influence of the Cholinergic System on the Pathogenesis of Glioblastoma: Impact of the Neutrophil Granulocytes

  2025cites this paper
• Sirtuins and tumor immunity: mechanistic insights, immunotherapy prospects, and therapeutic horizons

  2025cites this paper
• Neutrophils in non-small cell lung cancer and immunotherapy with PD-1/PD-L1 inhibitors

  2025cites this paper
• Granulocyte colony‐stimulating factor induced T‐cell hyporesponsiveness via modulation of CD177+S100Ahi neutrophils in unexplained recurrent pregnancy loss

  2025cites this paper
• Unraveling the molecular-pathological characteristics and cellular complexity of the tumor immune microenvironment in metastatic non-small cell lung cancer

  2025cites this paper
• A Refined Prognostic Model for Postoperative Overall Survival in Hepatocellular Carcinoma Based on CODEX-Based Multiproteomics and Radiomics

  2025cites this paper
• Neutrophils in glioma microenvironment: from immune function to immunotherapy

  2024cites this paper
• NPC1 promotes the progression of hepatocellular carcinoma by mediating the accumulation of neutrophils into the tumor microenvironment

  2024cites this paper
• Immune Microenvironment and the Effect of Vascular Endothelial Growth Factor Inhibition in Hepatocellular Carcinoma

  2024cites this paper
• Neutrophils in cancer: from biology to therapy

  2024cites this paper
• Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patients

  2024cites this paper
• Targeting Gsk3a reverses immune evasion to enhance immunotherapy in hepatocellular carcinoma

  2024cites this paper
• Deep learning predicts the 1-year prognosis of pancreatic cancer patients using positive peritoneal washing cytology

  2024cites this paper
• CXCL5 impedes CD8+ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis

  2024cites this paper
• β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers

  2024cites this paper
• Neutrophils in pancreatic ductal adenocarcinoma: bridging preclinical insights to clinical prospects for improved therapeutic strategies

  2024cites this paper
• Circadian rhythm regulates the function of immune cells and participates in the development of tumors

  2024cites this paper
• The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance

  2024cites this paper
• The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy

  2024cites this paper
• Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy.

  2024cites this paper
• Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4

  2024cites this paper
• Characterizing Neutrophil Subtypes in Cancer Using scRNA Sequencing Demonstrates the Importance of IL1β/CXCR2 Axis in Generation of Metastasis-specific Neutrophils

  2024cites this paper
• Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit

  2024cites this paper
• Role of neutrophils on cancer cells and other immune cells in the tumor microenvironment.

  2023cites this paper
• Tumor‐infiltrating lymphocytes in patients undergoing esophagectomy following neoadjuvant DCF therapy

  2023cites this paper
• Neutrophils as potential therapeutic targets for breast cancer.

  2023cites this paper
• Extracellular Mechanisms of Neutrophils in Immune Cell Crosstalk

  2023cites this paper
• Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer

  2023cites this paper
• A novel CD47-blocking peptide fused to pro-apoptotic KLA repeat inhibits lung cancer growth in mice

  2023cites this paper
• Nasopharynx Battlefield: Cellular Immune Responses Mediated by Midkine in Nasopharyngeal Carcinoma and COVID-19

  2023cites this paper
• Insights into the Tumor-Stromal-Immune Cell Metabolism Crosstalk in Ovarian Cancer.

  2023cites this paper
• Characterising neutrophil subtypes in cancer using human and murine single-cell RNA sequencing datasets

  2023cites this paper
• Tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in relation to pathological complete remission to neoadjuvant therapy and prognosis in triple negative breast cancer.

  2023cites this paper
• Prognostic Significance of Advanced Lung Cancer Inflammation Index, a Nutritional and Inflammation Index, in Patients With Gastrointestinal Cancers: A Meta-analysis

  2023cites this paper
• Role of neuroinflammation in neurodegeneration development

  2023cites this paper
• New techniques: a roadmap for the development of HCC immunotherapy

  2023cites this paper
• Squamous cell carcinoma‐derived G‐CSF promotes tumor growth and metastasis in mice through neutrophil recruitment and tumor cell proliferation, associated with poor prognosis of the patients

  2023cites this paper
• Interplay between tumor-derived factors and tumor-associated neutrophils: opportunities for therapeutic interventions in cancer

  2023cites this paper
• Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives.

  2023cites this paper
• SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma

  2023cites this paper
• Understanding the functional relevance of oral neutrophils, phenotype and properties in OSCC

  2023cites this paper
• Characteristics of tumor microenvironment and novel immunotherapeutic strategies for non-small cell lung cancer

  2022cites this paper
• Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy

  2022cites this paper
• Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Mechanistic insights into the interplays between neutrophils and other immune cells in cancer development and progression

  2022cites this paper
• Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer

  2022cites this paper
• The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes

  2022cites this paper
• Immunotherapy: Reshape the Tumor Immune Microenvironment

  2022cites this paper
• Tumor-associated neutrophils and neutrophil-targeted cancer therapies.

  2022cites this paper
• Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy

  2022cites this paper
• High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs

  2022cites this paper
• Neutrophil‐T cell crosstalk and the control of the host inflammatory response

  2022cites this paper
• Role of tumor-associated neutrophils in lung cancer (Review)

  2022cites this paper
• An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma

  2022cites this paper
• N1 versus N2 and PMN‐MDSC: A critical appraisal of current concepts on tumor‐associated neutrophils and new directions for human oncology

  2022cites this paper
• Next-Generation Immunotherapies to Improve Anticancer Immunity

  2021cites this paper
• The Clinical Significance of DNA Damage Repair Signatures in Clear Cell Renal Cell Carcinoma

  2021cites this paper
• The dual role of neutrophils in cancer.

  2021cites this paper
• Neutrophil metabolism in the cancer context.

  2021cites this paper
• Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy

  2021cites this paper
• Neutrophil-to-Lymphocyte Ratio and Ferritin as Measurable Tools for Disease Burden and B Symptoms in Pediatric Patients With Hodgkin Lymphoma

  2021cites this paper
• Understanding and Improving Cellular Immunotherapies Against Cancer: From Cell-Manufacturing to Tumor-Immune Models.

  2021cites this paper
• Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled

  2021cites this paper
• Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells.

  2021cites this paper
• Neutrophil Interactions with the Lymphatic System

  2021cites this paper
• Exploring the longitudinal glioma microenvironment landscape uncovers reprogrammed pro-tumorigenic neutrophils in the bone marrow.

  2021cites this paper
• Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma

  2021cites this paper
• Neutrophils at the crossroads of acute viral infections and severity

  2021cites this paper
• The Neutrophil.

  2021cites this paper
• Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?

  2021cites this paper
• Immunotherapy in Pancreatic Adenocarcinoma: Beyond “Copy/Paste”

  2021cites this paper
• Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review

  2021influential citation
• Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance

  2021cites this paper